Theragent, a comprehensive cell & gene therapy CDMO focused on advancing next-generation cancer and rare disease treatments, announced that Brian Newsom will be joining the team as their new Vice President of Business Development effective October 16th, 2023. Mr. Newsom will join Theragent from his latest role as Senior Director of Business Development at KBI Biopharma.
Mr. Newsom brings with him a three-decade mix of both technical and business development experience within the cell therapy industry. After spending 15 years in technical roles at emerging biotech companies and academia, including Aastrom Biosciences, Baylor College of Medicine, and Opexa Therapeutics, he then held business development positions of increasing responsibility at Invitrogen, Life Technologies, Thermo Fisher Scientific and KBI Biopharma. He received his undergraduate degree in microbiology from Texas Tech University and his MBA from Texas A&M University.
“We are excited to have Brian join us as we enter the expansion phase of our company,” said Yun Yen, MD, PhD, and CEO of Theragent. “Brian’s technical knowledge, business development background and CDMO experience will help drive our continued growth as we expand our presence in the cell and gene therapy market. He understands our unique capabilities in which we help biopharma companies develop even the most complex cell-based therapeutics, and he brings a strategic vision that aligns with our mission and long-term goals of helping to bring these products to patients in need.”
Mr. Newsom will lead Theragent’s global business development, marketing, and client relations activities.
About Theragent
Theragent is an advanced therapeutics Contract Development Manufacturing Organization in Arcadia, CA that facilitates the realization of novel cell and gene therapies for the treatment of cancer and rare diseases. The company’s innovative cGMP facility offers comprehensive end-to-end manufacturing and in-house testing capabilities for clinical and commercial purposes. With an emphasis on quality, safety, and manufacturing, Theragent strives to provide value-added solutions for clients with especially challenging pre-clinical and clinical trial projects.
Theragent. Patients are waiting. For more information, visit www.theragent.com.